Skip to content
GLP-1 Scorecard
Menu
Site position #369

SexyMD

Edited by Dana WhitfieldUpdated

Every price SexyMD advertises is a 48-week commitment rate, and the month-to-month figures behind them are $70 higher on each molecule.

Visit SexyMD ↗We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$269/mo (four-week plan; the $199 in every headline is the 48-week rate)
Tirzepatide
$369/mo (four-week plan; the $299 in every headline is the 48-week rate)
Coverage
47 states (all except Arkansas, Mississippi and New Jersey)
Brand-name
Not confirmed

Weigh SexyMD against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value38/100
Dose & formulation64/100
Clinical oversight73/100
Labs & monitoring52/100
Fulfillment85/100
Contract terms67/100

Strengths

  • Publishes an exact exclusion list — all states except Arkansas, Mississippi and New Jersey — rather than a nationwide claim
  • States both compounding classes in the Terms, so the class question is answered even though the pharmacy is not named
  • Names the prescribing entity and the professional corporation behind it
  • Sells two microdose products with their own published price tables rather than only as a discount tier

Where it loses points

  • Every headline price is the 48-week commitment rate: $199 against a month-to-month figure of $269, and $299 against $369, with an asterisk that resolves to no footnote
  • The same footer, on every page, says both that the service is available in all 50 states and that it is available in all states except three
  • The two microdose products publish identical prices for their 4-, 8- and 12-week plans, in the same table format that carries real tiers elsewhere
  • The microdose page contradicts itself on dosing frequency inside a single page
  • Three unsourced and mutually inconsistent social-proof figures appear across the homepage, the footer and the product pages
  • The checkout claims two patient counts for a single day that together exceed the total the site's own badge claims
  • No pharmacy is named, and what the price includes is never itemized on any product page

Bottom line — Grade C

Best for: Shoppers who intend to stay a full year and want a microdose option, and who will read the plan table rather than the headline.

Site position #369 of 542. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest SexyMD — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect SexyMD's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on SexyMD's site. Not medical advice; see our disclosure.

← Back to the scorecard